4DMedical successfully completes A$40m placement
Filed with ASX · · 3 pages · English
4DMEDICAL SUCCESSFULLY COMPLETES A$40M PLACEMENT TO SUPPORT DEVELOPMENT & COMMERCIALISATION OF XVD SCANNERS™ • Proceeds from the Placement will primarily fund, in conjunction with the $28.9m of MRFF funding, the development and commercialisation of the world’s first dedicated lung function scanner – XVD Scanner™. It was a commitment of the grant bid to the MRFF that 4DMedical provide new capital f
In the deck
Earlier from 4DMedical
- 4DMedical-led consortium awarded $28.9m MRFF grant
- Voluntary Suspension
- 4DMedical reports 1H FY21 results
- Quarterly Activity Report and Appendix 4C for Q2 FY202
- First U.S. clinical pilot for XV LVAS at St. Joseph Hospital
Later from 4DMedical
- Award of MRFF Frontier grant & capital raising presentation
- S&P DJI Announces March 2021 Quarterly Rebalance
- 4DMedical raises $6m in strongly supported SPP
- Quarterly Activity Report and Appendix 4C for Q3 FY2021
- 4DMedical receives US$600k order for preclinical scanner
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical